Hansa Biopharma AB (publ), a biopharmaceutical company, develops immunomodulatory treatments for enabling transplants and rare immunoglobulin G (IgG)-mediated autoimmune conditions, gene therapy, and cancer using its proprietary enzyme technology platform. The company's lead drug candidate is Imlifidase, an antibody cleaving enzyme therapy that is in phase 3 clinical trial for use in sensitized kidney transplantations patients, as well as for anti-GBM antibody disease; and phase 2 clinical trial for antibody-mediated kidney transplant rejection and Guillain Barré syndrome. It is also developing Novel immunoglobulin cleaving enzymes for Repeat dosing (NiceR) for the treatment of autoimmune diseases, transplantation, and oncology; and Enzyme based antibody Enhancement (EnzE), which is cancer immunotherapy. The company has a preclinical research collaboration agreement with argenx BV to evaluate the therapeutic potential of combining the two companies' IgG-modulating technologies. Hansa Biopharma AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Hansa Biopharma.
Hansa Biopharma business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Hansa Biopharma are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Hansa Biopharma , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Hansa Biopharma including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Hansa Biopharma and all latest updates of the company are provided.
The 2025 version of Hansa Biopharma report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Hansa Biopharma- Key Facts
2.2 Hansa Biopharma- Geographic Locations
2.3 Hansa Biopharma- Subsidiaries and Affiliates
2.4 Hansa Biopharma- Business Divisions
2.5 Hansa Biopharma- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Hansa Biopharma Strategic Analysis Review
3.1 Hansa Biopharma- Key Strategies
3.2 Hansa Biopharma- Company Outlook Statement
3.3 Hansa Biopharma- SWOT Analysis
3.3.1 Hansa Biopharma- Key Strengths
3.3.2 Hansa Biopharma- Key Weaknesses
3.3.3 Hansa Biopharma- Potential Opportunities
3.3.4 Hansa Biopharma- Potential Threats
3.4 Hansa Biopharma- Key Competitors
4. Business Description of the Company
4.1 Hansa Biopharma- Business Overview
4.2 Hansa Biopharma- Operations by Segment
5 Products and Services Details
5.1 Hansa Biopharma- Key Products
5.2 Hansa Biopharma- Key Service Areas
5.3 Hansa Biopharma- Key Brands
6 Company Developments
6.1 Hansa Biopharma- Company History
6.2 Hansa Biopharma- Latest Developments
7 Financial Analysis
7.1 Hansa Biopharma- Income Statements
7.2 Hansa Biopharma- Balance Sheet
7.3 Hansa Biopharma- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Hansa Biopharma- Direct Competitors
8.2 Hansa Biopharma- Competitor Financial Ratios comparison
8.3 Hansa Biopharma- Competitor Stock Charts Comparison
8.4 Hansa Biopharma- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!